Intech Investment Management LLC Has $1.90 Million Stock Holdings in Plexus Corp. $PLXS

Key Points

• Intech Investment Management LLC raised its stake in Plexus Corp. by 34.2% in the first quarter, now owning 14,823 shares valued at approximately $1.9 million.
• Insiders sold a total of 14,356 shares of Plexus valued at nearly $1.93 million over the past three months, indicating significant insider trading activity.
• Plexus reported an EPS of $1.90 for the last quarter, exceeding analysts' expectations and marking a 6% increase in revenue year-over-year.

Intech Investment Management LLC boosted its position in Plexus Corp. (NASDAQ:PLXS - Free Report) by 34.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 14,823 shares of the technology company's stock after acquiring an additional 3,779 shares during the quarter. Intech Investment Management LLC owned 0.05% of Plexus worth $1,899,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Xponance Inc. boosted its holdings in Plexus by 4.8% in the first quarter. Xponance Inc. now owns 2,315 shares of the technology company's stock valued at $297,000 after acquiring an additional 106 shares during the last quarter. Fox Run Management L.L.C. lifted its stake in shares of Plexus by 7.2% during the first quarter. Fox Run Management L.L.C. now owns 2,017 shares of the technology company's stock worth $258,000 after purchasing an additional 135 shares in the last quarter. Squarepoint Ops LLC lifted its stake in shares of Plexus by 1.1% during the fourth quarter. Squarepoint Ops LLC now owns 13,846 shares of the technology company's stock worth $2,167,000 after purchasing an additional 148 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Plexus by 1.6% during the first quarter. Nisa Investment Advisors LLC now owns 12,773 shares of the technology company's stock worth $1,637,000 after purchasing an additional 205 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in shares of Plexus by 49.2% during the first quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock worth $108,000 after purchasing an additional 279 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Analyst Ratings Changes

A number of research analysts have commented on PLXS shares. Benchmark restated a "buy" rating and set a $160.00 price objective on shares of Plexus in a research note on Wednesday, June 4th. Wall Street Zen cut Plexus from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 16th. Stifel Nicolaus set a $140.00 price objective on Plexus in a research note on Thursday, July 24th. Sidoti upgraded Plexus from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Finally, Needham & Company LLC reduced their price objective on Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research note on Thursday, July 24th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $152.00.

Insider Activity at Plexus

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the stock in a transaction on Monday, August 25th. The stock was sold at an average price of $137.78, for a total transaction of $217,141.28. Following the completion of the sale, the chief accounting officer owned 24,495 shares in the company, valued at approximately $3,374,921.10. This represents a 6.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $134.54, for a total value of $201,810.00. Following the sale, the chief executive officer owned 70,714 shares of the company's stock, valued at $9,513,861.56. This trade represents a 2.08% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,356 shares of company stock worth $1,926,890. 1.76% of the stock is owned by corporate insiders.

Plexus Stock Performance

Shares of NASDAQ PLXS traded down $1.76 during midday trading on Friday, hitting $141.00. 707,178 shares of the company's stock were exchanged, compared to its average volume of 138,611. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. The stock's 50 day moving average price is $133.65 and its 200-day moving average price is $130.26. The firm has a market cap of $3.81 billion, a P/E ratio of 24.02 and a beta of 0.82. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.19. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Equities research analysts anticipate that Plexus Corp. will post 5.9 EPS for the current year.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.